Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,924 | 29,380 | 18,447 | 8,597 | 32,478 |
| Depreciation Amortization | 15,987 | 11,346 | 7,178 | 2,983 | 11,759 |
| Income taxes - deferred | 1,543 | N/A | 4,693 | 1,709 | N/A |
| Accounts receivable | -15,272 | -6,681 | -967 | 413 | -2,431 |
| Accounts payable and accrued liabilities | 3,270 | 3,237 | -1,866 | 1,079 | -7,648 |
| Other Working Capital | -30,671 | -11,592 | -13,651 | -1,306 | -6,703 |
| Other Operating Activity | 24,071 | 9,238 | 5,689 | 337 | 14,688 |
| Operating Cash Flow | $36,852 | $34,928 | $19,523 | $13,812 | $42,143 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,068 | -2,990 | -2,375 | -1,399 | -4,239 |
| Net Acquisitions | -14,284 | -11,559 | -11,559 | -12,078 | -4,925 |
| Purchase Sale Intangibles | -1,126 | -1,158 | -890 | N/A | -1,481 |
| Other Investing Activity | -1,126 | -1,158 | -890 | 0 | -1,481 |
| Investing Cash Flow | $-19,478 | $-15,707 | $-14,824 | $-13,477 | $-10,645 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 0 | N/A | -38,017 |
| Common Stock Issued | 10,258 | 6,086 | 5,715 | 1,319 | 16,210 |
| Common Stock Repurchased | -11,525 | -13,655 | -5,515 | -1,312 | -4,633 |
| Other Financing Activity | 2,099 | 4,640 | 2,058 | 594 | 5,526 |
| Financing Cash Flow | $832 | $-2,929 | $2,258 | $601 | $-20,914 |
| Exchange Rate Effect | -2,295 | -649 | -277 | -495 | -132 |
| Beginning Cash Position | 66,558 | 66,558 | 66,558 | 66,558 | 56,106 |
| End Cash Position | 82,469 | 82,201 | 73,238 | 66,999 | 66,558 |
| Net Cash Flow | $15,911 | $15,643 | $6,680 | $441 | $10,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,852 | 34,928 | 19,523 | 13,812 | 42,143 |
| Capital Expenditure | -4,068 | -2,990 | -2,375 | -1,399 | -4,239 |
| Free Cash Flow | 32,784 | 31,938 | 17,148 | 12,413 | 37,904 |